Lucid Diagnostics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lucid Diagnostics Inc: Is Infosys Ltd. worth buying?
Item: Lucid Diagnostics Inc
Rating: 1.21491675
Author: Trendlyne DVM scores

about

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

1.20 -0.01 (-0.83%)

33.33% Fall from 52W High

184.4K

XNAS Volume

XNAS 04 Nov, 2025 10:25 AM (EST)

Board Meeting

The next board meeting for Lucid Diagnostics Inc is on 13 Nov 2025 for the purpose of Lucid Diagnostics Inc Third Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

1.2 / 100

Technically Neutral

47.4 / 100

1Yr Price target upside is 212%

6 analysts

Lucid Diagnostics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lucid Diagnostics Inc Live Stock Price Today, Share Analysis and Chart

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

33.33% Fall from 52W High

SWOT Analysis

Lucid Diagnostics Inc Live Price Chart